Pradhan S, Shrestha PS, Shrestha GS, et al. - Whether performing lung-ultrasound monitoring could enable early detection of ventilator-associated pneumonia (VAP) as well as an improved patient outcome, was explored in this single-center diagnostic randomized controlled trial. This study included a control group, in which, a combination of chest x-ray (CXR) and clinical findings was used to diagnose VAP. For diagnosing VAP, a combination of lung-ultrasound and clinical findings was used in the intervention group. Ventilator free days (VFD) were assessed as the primary outcome. In the intervention group vs in the control group, a higher VFD was reported. ICU mortality, ICU length of stay, ventilator days, delta SOFA and antibiotic duration did not differ between the groups. Overall, findings revealed that an improved patient outcome was achieved with the use of lung-ultrasound monitoring for diagnosis of VAP vs the standard diagnostic strategy that depends on CXR.